Showing results (101-110 of 124) with videos related to

Sort By:
Pageof 13
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|December 29, 2016
Prognostic factors in 868 advanced gastric cancer patients treated with second-line chemotherapy in the real worldValentina Fanotto, Stefano Cordio, Giulia Pasquini, et al.
The Oncologist|April 7, 2019
HER2 Positivity Predicts Unresponsiveness to EGFR-Targeted Treatment in Metastatic Colorectal CancerAndrea Sartore-Bianchi, Alessio Amatu, Luca Porcu, et al.
ESMO Open|September 29, 2020
Pertuzumab and trastuzumab emtansine in patients with HER2-amplified metastatic colorectal cancer: the phase II HERACLES-B trialAndrea Sartore-Bianchi, Sara Lonardi, Cosimo Martino, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 28, 2019
The prognostic nutritional index predicts survival and response to first-line chemotherapy in advanced biliary cancerMassimiliano Salati, Roberto Filippi, Caterina Vivaldi, et al.
Clinical Colorectal Cancer|October 1, 2019
Validated Nomogram Predicting 6-Month Survival in Pancreatic Cancer Patients Receiving First-Line 5-Fluorouracil, Oxaliplatin, and IrinotecanLorenzo Fornaro, Francesco Leone, Angélique Vienot, et al.
International Journal of Cancer|March 16, 2018
Colorectal cancer early methylation alterations affect the crosstalk between cell and surrounding environment, tracing a biomarker signature specific for this tumorAntonio Fadda, Davide Gentilini, Loredana Moi, et al.
Journal of Hepatology|December 28, 2025
Molecular profiling and matched targeted treatment in cholangiocarcinoma: results from the Italian dataset (ANITA)Virginia Genovesi, Francesca Salani, Margherita Rimini, et al.
Oncology|February 24, 2021
Effects of Metformin and Vitamin D on Clinical Outcome in Cholangiocarcinoma PatientsAndrea Casadei-Gardini, Roberto Filippi, Margherita Rimini, et al.
Clinical Colorectal Cancer|September 13, 2020
Long-term Clinical Outcome of Trastuzumab and Lapatinib for HER2-positive Metastatic Colorectal CancerFederica Tosi, Andrea Sartore-Bianchi, Sara Lonardi, et al.
Oncology|August 22, 2018
Estimating Survival Probabilities of Advanced Gastric Cancer Patients in the Second-Line Setting: The Gastric Life NomogramFilippo Pietrantonio, Francesco Barretta, Valentina Fanotto, et al.
Pageof 13